Our mission is to revolutionize care delivery through the practical application of clinical AI.
External link for Lucem Health
Raleigh, North Carolina, US
Lucem Health reposted this
Liver disease rarely headlines health discussions, yet MASLD and MASH are silent, growing threats – affecting about 25% of adults. With obesity, diabetes, and other major factors contributing to their rise, learn why early detection and diagnosis are crucial in our latest blog post. #EarlyDetection #LiverDisease #MASLD #MASH Read the blog post: https://hubs.ly/Q02Q8NwR0
Lucem Health reposted this
Catching liver disease early isn't just smart – it pays off financially too. Dig into the details with our latest post about how it leads to reduced downstream care costs and new opportunities for revenue acceleration. #LiverDisease #EarlyDetection #MASH #MASLD https://hubs.ly/Q02QZp5G0
Going from lifestyle modifications to resmetirom and GLP-1 receptor agonists – a look at the evolving landscape of treatment for MASLD and MASH. #LiverDisease #MASH #MASLD https://hubs.ly/Q02S-Z8s0
We're encouraged to see The New York Times bringing attention to Metabolic Associated Steatotic Liver Disease (MASLD) in their recent article. Raising awareness is a vital first step in addressing this growing health challenge. By focusing on supporting healthcare providers with the tools and knowledge they need, we can significantly improve early detection and management of MASLD. Empowered providers lead to better-informed care decisions, ultimately benefiting patients with more effective treatments and improved outcomes. https://lnkd.in/gvxJdggi
🔍 From FIB-4 to AI: Uncover the promising future of liver disease detection and diagnostics. Can AI really improve accuracy? Find out in our latest post! #LiverDisease #EarlyDetection #MASH #MASLD https://hubs.ly/Q02Rgs-70
Catching liver disease early isn't just smart – it pays off financially too. Dig into the details with our latest post about how it leads to reduced downstream care costs and new opportunities for revenue acceleration. #LiverDisease #EarlyDetection #MASH #MASLD https://hubs.ly/Q02QZp5G0
NAFLD's reclassification as MASLD underscores the growing recognition of metabolic factors in liver pathology. This shift is expected to enhance patient screening and management strategies, aligning them more closely with emerging evidence and clinical needs. Learn about this change and what it means in our latest blog post. #LiverDisease #MASLD #MASH #EarlyDetection https://hubs.ly/Q02QtBpY0
Lucem Health reposted this
A great little amuse bouche on some new ways to think about precision medicine, from Mercy's recent Summit on the subject. Our own Conrad Gudmundson leads off the sound bites... enjoy!
Better care starts with personalization. At Mercy’s first Precision Medicine Summit, some of the nation's top experts talked about how giving each patient the right care for their unique needs leads to better results and healthier lives. Read more: https://ow.ly/zue250Tn9UL
Liver disease rarely headlines health discussions, yet MASLD and MASH are silent, growing threats – affecting about 25% of adults. With obesity, diabetes, and other major factors contributing to their rise, learn why early detection and diagnosis are crucial in our latest blog post. #EarlyDetection #LiverDisease #MASLD #MASH Read the blog post: https://hubs.ly/Q02Q8NwR0